{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:14:16Z","timestamp":1788588856890,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,14]],"date-time":"2014-11-14T00:00:00Z","timestamp":1415923200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12879-014-0587-z","type":"journal-article","created":{"date-parts":[[2014,11,13]],"date-time":"2014-11-13T14:02:28Z","timestamp":1415887348000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The safety and immunogenicity of a MF59-adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: an observational study"],"prefix":"10.1186","volume":"14","author":[{"given":"Sung-Hsi","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Tsan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Chou","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Hsin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Lung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Yee","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pesus","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,14]]},"reference":[{"issue":"21","key":"587_CR1","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1056\/NEJMp068205","volume":"355","author":"RG Webster","year":"2006","unstructured":"Webster RG, Govorkova EA: H5N1 influenza-continuing evolution and spread. N Engl J Med. 2006, 355 (21): 2174-2177. 10.1056\/NEJMp068205.","journal-title":"N Engl J Med"},{"issue":"5758","key":"587_CR2","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.311.5758.161b","volume":"311","author":"M Enserink","year":"2006","unstructured":"Enserink M: Avian influenza. More cases in Turkey, but no mutations found. Science. 2006, 311 (5758): 161-","journal-title":"Science"},{"issue":"6075","key":"587_CR3","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/science.1218888","volume":"335","author":"TT Wang","year":"2012","unstructured":"Wang TT, Parides MK, Palese P: Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science. 2012, 335 (6075): 1463-10.1126\/science.1218888.","journal-title":"Science"},{"issue":"2","key":"587_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1086\/505225","volume":"194","author":"EA Govorkova","year":"2006","unstructured":"Govorkova EA, Webby RJ, Humberd J, Seiler JP, Webster RG: Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J Infect Dis. 2006, 194 (2): 159-167. 10.1086\/505225.","journal-title":"J Infect Dis"},{"key":"587_CR5","unstructured":"Influenza A (H5N1) vaccine stockpile and inter-pandemic vaccine use background document. [], [http:\/\/www.who.int\/immunization\/sage\/meetings\/2013\/november\/SAGE_WG_H5vaccine_background_paper_16Oct2013_v4.pdf]"},{"key":"587_CR6","unstructured":"Strategic Advisory Group of Experts: recommendations on the use of licensed human H5N1 influenza vaccines in the interpandemic period. Releve epidemiologique hebdomadaire\/Section d\u2019hygiene du Secretariat de la Societe des Nations = Weekly epidemiological record\/Health Section of the Secretariat of the League of Nations. 2009, 84 (24): 244-248."},{"key":"587_CR7","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/1471-2458-10-322","volume":"10","author":"P Hanvoravongchai","year":"2010","unstructured":"Hanvoravongchai P, Adisasmito W, Chau PN, Conseil A, de Sa J, Krumkamp R, Mounier-Jack S, Phommasack B, Putthasri W, Shih CS, Touch S, Coker R: Pandemic influenza preparedness and health systems challenges in Asia: results from rapid analyses in 6 Asian countries. BMC Public Health. 2010, 10: 322-10.1186\/1471-2458-10-322.","journal-title":"BMC Public Health"},{"issue":"2","key":"587_CR8","doi-asserted-by":"publisher","first-page":"e31800","DOI":"10.1371\/journal.pone.0031800","volume":"7","author":"JW Rudge","year":"2012","unstructured":"Rudge JW, Hanvoravongchai P, Krumkamp R, Chavez I, Adisasmito W, Chau PN, Phommasak B, Putthasri W, Shih CS, Stein M, Timen A, Touch S, Reintjes R, Coker R: Health system resource gaps and associated mortality from pandemic influenza across six Asian territories. PLoS One. 2012, 7 (2): e31800-10.1371\/journal.pone.0031800.","journal-title":"PLoS One"},{"issue":"1","key":"587_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4161\/hv.26737","volume":"10","author":"WT Huang","year":"2014","unstructured":"Huang WT, Chang CH, Peng MC: Telephone monitoring of adverse events during an MF59(R)-adjuvanted H5N1 influenza vaccination campaign in Taiwan. Hum Vaccin Immunother. 2014, 10 (1): 100-103. 10.4161\/hv.26737.","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"587_CR10","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1128\/CVI.00461-09","volume":"17","author":"E Fragapane","year":"2010","unstructured":"Fragapane E, Gasparini R, Schioppa F, Laghi-Pasini F, Montomoli E, Banzhoff A: A heterologous MF59-adjuvanted H5N1 prepandemic influenza booster vaccine induces a robust, cross-reactive immune response in adults and the elderly. Clin Vaccine Immunol. 2010, 17 (11): 1817-1819. 10.1128\/CVI.00461-09.","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"587_CR11","doi-asserted-by":"publisher","first-page":"e4384","DOI":"10.1371\/journal.pone.0004384","volume":"4","author":"A Banzhoff","year":"2009","unstructured":"Banzhoff A, Gasparini R, Laghi-Pasini F, Staniscia T, Durando P, Montomoli E, Capecchi PL, di Giovanni P, Sticchi L, Gentile C, Hilbert A, Brauer V, Tilman S, Podda A: MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults. PLoS One. 2009, 4 (2): e4384-10.1371\/journal.pone.0004384.","journal-title":"PLoS One"},{"issue":"2","key":"587_CR12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1586\/14760584.2.2.197","volume":"2","author":"A Podda","year":"2003","unstructured":"Podda A, Del Giudice G: MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile. Expert Rev Vaccines. 2003, 2 (2): 197-203. 10.1586\/14760584.2.2.197.","journal-title":"Expert Rev Vaccines"},{"issue":"16","key":"587_CR13","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1016\/j.vaccine.2006.01.015","volume":"24","author":"G Del Giudice","year":"2006","unstructured":"Del Giudice G, Hilbert AK, Bugarini R, Minutello A, Popova O, Toneatto D, Schoendorf I, Borkowski A, Rappuoli R, Podda A: An MF59-adjuvanted inactivated influenza vaccine containing A\/Panama\/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A\/Fujian\/2002 than a subunit and a split influenza vaccine. Vaccine. 2006, 24 (16): 3063-3065. 10.1016\/j.vaccine.2006.01.015.","journal-title":"Vaccine"},{"issue":"2","key":"587_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1586\/erv.11.170","volume":"11","author":"R Gasparini","year":"2012","unstructured":"Gasparini R, Amicizia D, Lai PL, Panatto D: Aflunov((R)): a prepandemic influenza vaccine. Expert Rev Vaccines. 2012, 11 (2): 145-157. 10.1586\/erv.11.170.","journal-title":"Expert Rev Vaccines"},{"issue":"9587","key":"587_CR15","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0140-6736(07)61297-5","volume":"370","author":"I Leroux-Roels","year":"2007","unstructured":"Leroux-Roels I, Borkowski A, Vanwolleghem T, Drame M, Clement F, Hons E, Devaster JM, Leroux-Roels G: Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet. 2007, 370 (9587): 580-589. 10.1016\/S0140-6736(07)61297-5.","journal-title":"Lancet"},{"issue":"19","key":"587_CR16","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1016\/j.vaccine.2008.02.068","volume":"26","author":"HC Rumke","year":"2008","unstructured":"Rumke HC, Bayas JM, de Juanes JR, Caso C, Richardus JH, Campins M, Rombo L, Duval X, Romanenko V, Schwarz TF, Fassakhov R, Abad-Santos F, von Sonnenburg F, Drame M, Sanger R, Ballou WR: Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial. Vaccine. 2008, 26 (19): 2378-2388. 10.1016\/j.vaccine.2008.02.068.","journal-title":"Vaccine"},{"issue":"2","key":"587_CR17","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.vaccine.2011.10.088","volume":"30","author":"PA Tambyah","year":"2012","unstructured":"Tambyah PA, Wilder-Smith A, Pavlova BG, Barrett PN, Oh HM, Hui DS, Yuen KY, Fritsch S, Aichinger G, Loew-Baselli A, van der Velden M, Maritsch F, Kistner O, Ehrlich HJ: Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A\/Indonesia\/05\/2005) influenza vaccine. Vaccine. 2012, 30 (2): 329-335. 10.1016\/j.vaccine.2011.10.088.","journal-title":"Vaccine"},{"issue":"8","key":"587_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S1473-3099(04)01105-3","volume":"4","author":"I Stephenson","year":"2004","unstructured":"Stephenson I, Nicholson KG, Wood JM, Zambon MC, Katz JM: Confronting the avian influenza threat: vaccine development for a potential pandemic. Lancet Infect Dis. 2004, 4 (8): 499-509. 10.1016\/S1473-3099(04)01105-3.","journal-title":"Lancet Infect Dis"},{"issue":"1\u20132","key":"587_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.virusres.2004.02.019","volume":"103","author":"I Stephenson","year":"2004","unstructured":"Stephenson I, Wood JM, Nicholson KG, Charlett A, Zambon MC: Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A\/Duck\/Singapore\/97 vaccine. Virus Res. 2004, 103 (1\u20132): 91-95. 10.1016\/j.virusres.2004.02.019.","journal-title":"Virus Res"},{"issue":"3","key":"587_CR20","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.vaccine.2009.10.017","volume":"28","author":"I Leroux-Roels","year":"2010","unstructured":"Leroux-Roels I, Roman F, Forgus S, Maes C, De Boever F, Drame M, Gillard P, van der Most R, Van Mechelen M, Hanon E, Leroux-Roels G: Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. Vaccine. 2010, 28 (3): 849-857. 10.1016\/j.vaccine.2009.10.017.","journal-title":"Vaccine"},{"issue":"37","key":"587_CR21","doi-asserted-by":"publisher","first-page":"6408","DOI":"10.1016\/j.vaccine.2011.04.072","volume":"29","author":"G Risi","year":"2011","unstructured":"Risi G, Frenette L, Langley JM, Li P, Riff D, Sheldon E, Vaughn DW, Fries L: Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: results of a randomised single heterologous booster dose study at 15 months. Vaccine. 2011, 29 (37): 6408-6418. 10.1016\/j.vaccine.2011.04.072.","journal-title":"Vaccine"},{"issue":"24","key":"587_CR22","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1016\/j.vaccine.2011.03.084","volume":"29","author":"D Ikeno","year":"2011","unstructured":"Ikeno D, Kimachi K, Ibaragi K, Kudo Y, Goto S, Odoh K, Itamura S, Odagiri T, Tashiro M, Kino Y: Differences in the priming effect of various clades\/subclades of inactivated H5N1 vaccine for booster injection with heterologous clades of vaccine strains. Vaccine. 2011, 29 (24): 4156-4161. 10.1016\/j.vaccine.2011.03.084.","journal-title":"Vaccine"},{"issue":"3","key":"587_CR23","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.vaccine.2009.10.105","volume":"28","author":"N Sabarth","year":"2010","unstructured":"Sabarth N, Howard MK, Savidis-Dacho H, van Maurik A, Barrett PN, Kistner O: Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model. Vaccine. 2010, 28 (3): 650-656. 10.1016\/j.vaccine.2009.10.105.","journal-title":"Vaccine"},{"issue":"45","key":"587_CR24","doi-asserted-by":"publisher","first-page":"6284","DOI":"10.1016\/j.vaccine.2009.01.040","volume":"27","author":"TF Schwarz","year":"2009","unstructured":"Schwarz TF, Horacek T, Knuf M, Damman HG, Roman F, Drame M, Gillard P, Jilg W: Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults. Vaccine. 2009, 27 (45): 6284-6290. 10.1016\/j.vaccine.2009.01.040.","journal-title":"Vaccine"},{"issue":"1","key":"587_CR25","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1750-2659.2012.00349.x","volume":"7","author":"P Gillard","year":"2013","unstructured":"Gillard P, Caplanusi A, Knuf M, Roman F, Walravens K, Moris P, Drame M, Schwarz TF: An assessment of prime-boost vaccination schedules with AS03A -adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults. Influenza Other Respir Viruses. 2013, 7 (1): 55-65. 10.1111\/j.1750-2659.2012.00349.x.","journal-title":"Influenza Other Respir Viruses"},{"issue":"1","key":"587_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1637\/8960-061709-Reg.1","volume":"54","author":"MC Cheng","year":"2010","unstructured":"Cheng MC, Lee MS, Ho YH, Chyi WL, Wang CH: Avian influenza monitoring in migrating birds in Taiwan during 1998\u20132007. Avian Dis. 2010, 54 (1): 109-114. 10.1637\/8960-061709-Reg.1.","journal-title":"Avian Dis"},{"issue":"4","key":"587_CR27","doi-asserted-by":"publisher","first-page":"e36120","DOI":"10.1371\/journal.pone.0036120","volume":"7","author":"JH Chuang","year":"2012","unstructured":"Chuang JH, Huang AS, Huang WT, Liu MT, Chou JH, Chang FY, Chiu WT: Nationwide surveillance of influenza during the pandemic (2009\u201310) and post-pandemic (2010\u201311) periods in Taiwan. PLoS One. 2012, 7 (4): e36120-10.1371\/journal.pone.0036120.","journal-title":"PLoS One"},{"issue":"13","key":"587_CR28","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMoa055778","volume":"354","author":"JJ Treanor","year":"2006","unstructured":"Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M: Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med. 2006, 354 (13): 1343-1351. 10.1056\/NEJMoa055778.","journal-title":"N Engl J Med"},{"issue":"1","key":"587_CR29","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3201\/eid1401.061283","volume":"14","author":"C Gioia","year":"2008","unstructured":"Gioia C, Castilletti C, Tempestilli M, Piacentini P, Bordi L, Chiappini R, Agrati C, Squarcione S, Ippolito G, Puro V, Capobianchi MR, Poccia F: Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza. Emerg Infect Dis. 2008, 14 (1): 121-128. 10.3201\/eid1401.061283.","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"587_CR30","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.3201\/eid1508.081754","volume":"15","author":"I Stephenson","year":"2009","unstructured":"Stephenson I, Heath A, Major D, Newman RW, Hoschler K, Junzi W, Katz JM, Weir JP, Zambon MC, Wood JM: Reproducibility of serologic assays for influenza virus A (H5N1). Emerg Infect Dis. 2009, 15 (8): 1252-1259. 10.3201\/eid1508.081754.","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"587_CR31","first-page":"43","volume":"52","author":"GC Schild","year":"1975","unstructured":"Schild GC, Pereira MS, Chakraverty P: Single-radial-hemolysis: a new method for the assay of antibody to influenza haemagglutinin. Applications for diagnosis and seroepidemiologic surveillance of influenza. Bull World Health Organ. 1975, 52 (1): 43-50.","journal-title":"Bull World Health Organ"},{"issue":"9272","key":"587_CR32","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1016\/S0140-6736(00)05066-2","volume":"357","author":"KG Nicholson","year":"2001","unstructured":"Nicholson KG, Colegate AE, Podda A, Stephenson I, Wood J, Ypma E, Zambon MC: Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A\/Duck\/Singapore\/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet. 2001, 357 (9272): 1937-1943. 10.1016\/S0140-6736(00)05066-2.","journal-title":"Lancet"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-014-0587-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0587-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0587-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0587-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T04:19:14Z","timestamp":1650601154000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-014-0587-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,14]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["587"],"URL":"https:\/\/doi.org\/10.1186\/s12879-014-0587-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,14]]},"assertion":[{"value":"9 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"587"}}